Loading…
Chemometry‐assisted UV‐spectrophotmetric methods for the simultaneous determination of paritaprevir, ritonavir, and ombitasvir in their combined tablet dosage forms: A comparative study
The ternary mixture under study is a recent hepatitis‐C antiviral medicine composed of three new directly acting antiviral drugs, namely, ombitasvir, paritaprevir, and ritonavir. They are co‐formulated as a single‐dose combined tablet dosage form. With more than 170 million infected patients worldwi...
Saved in:
Published in: | Journal of chemometrics 2021-05, Vol.35 (5), p.n/a |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c2939-c3c8f276cc823de1bf582e030f654c9ce2b71d26debd76975a40dfcd2fc83d893 |
---|---|
cites | cdi_FETCH-LOGICAL-c2939-c3c8f276cc823de1bf582e030f654c9ce2b71d26debd76975a40dfcd2fc83d893 |
container_end_page | n/a |
container_issue | 5 |
container_start_page | |
container_title | Journal of chemometrics |
container_volume | 35 |
creator | Sayed, Rania Adel Ibrahim, Adel Ehab Sharaf, Yasmine Ahmed |
description | The ternary mixture under study is a recent hepatitis‐C antiviral medicine composed of three new directly acting antiviral drugs, namely, ombitasvir, paritaprevir, and ritonavir. They are co‐formulated as a single‐dose combined tablet dosage form. With more than 170 million infected patients worldwide, a large production scales of antivirals medicine is expected, and hence, new simple and fast methodologies are required to cover millions of analyses that are done routinely in the different pharmaceutical quality control and research laboratories. Ultraviolet spectrophotometry represents sensitive, fast, and cheap tool of analysis in all research and quality control laboratories that can cover the massive quality control of these regimens. However, the simultaneous determination of these three drugs using multivariate chemometric methods represents a high challenge as their spectra are strongly overlapping besides the large difference in their potency within the same tablet. In this research paper, four new different multivariate chemometric methods were developed for their simultaneous determination, namely, classical least square (CLS), principal component regression (PCR), partial least squares (PLS), and genetic algorithm‐partial least squares (GA‐PLS) techniques. The validated methods do not require extraction, separation, or derivatization steps. A comparative study was conducted among the four developed methods. All methods provided satisfactory results, whereas GA‐PLS showed better analytical performance as it had the lowest error with good higher correlation coefficient. The methods were applied in the simultaneous determination of the three drugs in pure form and in their combined tablet dosage form. The comparison confirmed agreement of the values obtained for all techniques.
Ombitasvir, paritaprevir, and ritonavir are coformulated as a single‐dose combined tablet dosage form. In this research paper, four new different multivariate chemometric methods were developed for their simultaneous determination, namely, classical least square (CLS), principal component regression (PCR), partial least squares (PLS), and genetic algorithm‐partial least squares (GA‐PLS) techniques. The methods were applied in the simultaneous determination of the three drugs in pure form and in their combined tablet dosage form. |
doi_str_mv | 10.1002/cem.3339 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2525442775</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2525442775</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2939-c3c8f276cc823de1bf582e030f654c9ce2b71d26debd76975a40dfcd2fc83d893</originalsourceid><addsrcrecordid>eNp1kUtO9DAQhC0EEsND4giW_g0LAo6dh_3v0IiXBGIDiF3k2G3GaBIH2wHNjiNwIS7DSXAYtqy6uutT1aIROsjJcU4IPVHQHTPGxAaa5USILKf8cRPNCOdVJhhn22gnhGdCkseKGfqcL6BzHUS_-nr_kCHYEEHj-4e0hQFU9G5YuDgBVuE0Fk4HbJzHcQE42G5cRtmDGwPWEMF3tpfRuh47gwfpbZSDh1frj3DSrpc_UvYau65NZkg7tv0UloSajn2qj7JdQsTaBfkEU1sX_uPTyU-ZKf81VcdRr_bQlpHLAPu_cxfdn5_dzS-z69uLq_npdaaoYCJTTHFD60opTpmGvDUlp0AYMVVZKKGAtnWuaaWh1XUl6lIWRBulqVGcaS7YLvq3zh28exkhxObZjb5PlQ0taVkUtK7LRB2uKeVdCB5MM3jbSb9qctJMz2nSc5rpOQnN1uibXcLqT66Zn9388N-LIJjz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2525442775</pqid></control><display><type>article</type><title>Chemometry‐assisted UV‐spectrophotmetric methods for the simultaneous determination of paritaprevir, ritonavir, and ombitasvir in their combined tablet dosage forms: A comparative study</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Sayed, Rania Adel ; Ibrahim, Adel Ehab ; Sharaf, Yasmine Ahmed</creator><creatorcontrib>Sayed, Rania Adel ; Ibrahim, Adel Ehab ; Sharaf, Yasmine Ahmed</creatorcontrib><description>The ternary mixture under study is a recent hepatitis‐C antiviral medicine composed of three new directly acting antiviral drugs, namely, ombitasvir, paritaprevir, and ritonavir. They are co‐formulated as a single‐dose combined tablet dosage form. With more than 170 million infected patients worldwide, a large production scales of antivirals medicine is expected, and hence, new simple and fast methodologies are required to cover millions of analyses that are done routinely in the different pharmaceutical quality control and research laboratories. Ultraviolet spectrophotometry represents sensitive, fast, and cheap tool of analysis in all research and quality control laboratories that can cover the massive quality control of these regimens. However, the simultaneous determination of these three drugs using multivariate chemometric methods represents a high challenge as their spectra are strongly overlapping besides the large difference in their potency within the same tablet. In this research paper, four new different multivariate chemometric methods were developed for their simultaneous determination, namely, classical least square (CLS), principal component regression (PCR), partial least squares (PLS), and genetic algorithm‐partial least squares (GA‐PLS) techniques. The validated methods do not require extraction, separation, or derivatization steps. A comparative study was conducted among the four developed methods. All methods provided satisfactory results, whereas GA‐PLS showed better analytical performance as it had the lowest error with good higher correlation coefficient. The methods were applied in the simultaneous determination of the three drugs in pure form and in their combined tablet dosage form. The comparison confirmed agreement of the values obtained for all techniques.
Ombitasvir, paritaprevir, and ritonavir are coformulated as a single‐dose combined tablet dosage form. In this research paper, four new different multivariate chemometric methods were developed for their simultaneous determination, namely, classical least square (CLS), principal component regression (PCR), partial least squares (PLS), and genetic algorithm‐partial least squares (GA‐PLS) techniques. The methods were applied in the simultaneous determination of the three drugs in pure form and in their combined tablet dosage form.</description><identifier>ISSN: 0886-9383</identifier><identifier>EISSN: 1099-128X</identifier><identifier>DOI: 10.1002/cem.3339</identifier><language>eng</language><publisher>Chichester: Wiley Subscription Services, Inc</publisher><subject>Antiretroviral drugs ; Antiviral drugs ; Chemometrics ; Comparative studies ; Correlation coefficient ; Correlation coefficients ; Dosage ; Drug dosages ; Drugs ; Genetic algorithms ; Hepatitis ; Laboratories ; Least squares ; Medicine ; Multivariate analysis ; multivariate chemometry ; ombitasvir ; paritaprevir ; Quality control ; Ritonavir ; Scientific papers ; Spectrophotometry</subject><ispartof>Journal of chemometrics, 2021-05, Vol.35 (5), p.n/a</ispartof><rights>2021 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2939-c3c8f276cc823de1bf582e030f654c9ce2b71d26debd76975a40dfcd2fc83d893</citedby><cites>FETCH-LOGICAL-c2939-c3c8f276cc823de1bf582e030f654c9ce2b71d26debd76975a40dfcd2fc83d893</cites><orcidid>0000-0001-7421-1220</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Sayed, Rania Adel</creatorcontrib><creatorcontrib>Ibrahim, Adel Ehab</creatorcontrib><creatorcontrib>Sharaf, Yasmine Ahmed</creatorcontrib><title>Chemometry‐assisted UV‐spectrophotmetric methods for the simultaneous determination of paritaprevir, ritonavir, and ombitasvir in their combined tablet dosage forms: A comparative study</title><title>Journal of chemometrics</title><description>The ternary mixture under study is a recent hepatitis‐C antiviral medicine composed of three new directly acting antiviral drugs, namely, ombitasvir, paritaprevir, and ritonavir. They are co‐formulated as a single‐dose combined tablet dosage form. With more than 170 million infected patients worldwide, a large production scales of antivirals medicine is expected, and hence, new simple and fast methodologies are required to cover millions of analyses that are done routinely in the different pharmaceutical quality control and research laboratories. Ultraviolet spectrophotometry represents sensitive, fast, and cheap tool of analysis in all research and quality control laboratories that can cover the massive quality control of these regimens. However, the simultaneous determination of these three drugs using multivariate chemometric methods represents a high challenge as their spectra are strongly overlapping besides the large difference in their potency within the same tablet. In this research paper, four new different multivariate chemometric methods were developed for their simultaneous determination, namely, classical least square (CLS), principal component regression (PCR), partial least squares (PLS), and genetic algorithm‐partial least squares (GA‐PLS) techniques. The validated methods do not require extraction, separation, or derivatization steps. A comparative study was conducted among the four developed methods. All methods provided satisfactory results, whereas GA‐PLS showed better analytical performance as it had the lowest error with good higher correlation coefficient. The methods were applied in the simultaneous determination of the three drugs in pure form and in their combined tablet dosage form. The comparison confirmed agreement of the values obtained for all techniques.
Ombitasvir, paritaprevir, and ritonavir are coformulated as a single‐dose combined tablet dosage form. In this research paper, four new different multivariate chemometric methods were developed for their simultaneous determination, namely, classical least square (CLS), principal component regression (PCR), partial least squares (PLS), and genetic algorithm‐partial least squares (GA‐PLS) techniques. The methods were applied in the simultaneous determination of the three drugs in pure form and in their combined tablet dosage form.</description><subject>Antiretroviral drugs</subject><subject>Antiviral drugs</subject><subject>Chemometrics</subject><subject>Comparative studies</subject><subject>Correlation coefficient</subject><subject>Correlation coefficients</subject><subject>Dosage</subject><subject>Drug dosages</subject><subject>Drugs</subject><subject>Genetic algorithms</subject><subject>Hepatitis</subject><subject>Laboratories</subject><subject>Least squares</subject><subject>Medicine</subject><subject>Multivariate analysis</subject><subject>multivariate chemometry</subject><subject>ombitasvir</subject><subject>paritaprevir</subject><subject>Quality control</subject><subject>Ritonavir</subject><subject>Scientific papers</subject><subject>Spectrophotometry</subject><issn>0886-9383</issn><issn>1099-128X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kUtO9DAQhC0EEsND4giW_g0LAo6dh_3v0IiXBGIDiF3k2G3GaBIH2wHNjiNwIS7DSXAYtqy6uutT1aIROsjJcU4IPVHQHTPGxAaa5USILKf8cRPNCOdVJhhn22gnhGdCkseKGfqcL6BzHUS_-nr_kCHYEEHj-4e0hQFU9G5YuDgBVuE0Fk4HbJzHcQE42G5cRtmDGwPWEMF3tpfRuh47gwfpbZSDh1frj3DSrpc_UvYau65NZkg7tv0UloSajn2qj7JdQsTaBfkEU1sX_uPTyU-ZKf81VcdRr_bQlpHLAPu_cxfdn5_dzS-z69uLq_npdaaoYCJTTHFD60opTpmGvDUlp0AYMVVZKKGAtnWuaaWh1XUl6lIWRBulqVGcaS7YLvq3zh28exkhxObZjb5PlQ0taVkUtK7LRB2uKeVdCB5MM3jbSb9qctJMz2nSc5rpOQnN1uibXcLqT66Zn9388N-LIJjz</recordid><startdate>202105</startdate><enddate>202105</enddate><creator>Sayed, Rania Adel</creator><creator>Ibrahim, Adel Ehab</creator><creator>Sharaf, Yasmine Ahmed</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7SC</scope><scope>7U5</scope><scope>8FD</scope><scope>JQ2</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><orcidid>https://orcid.org/0000-0001-7421-1220</orcidid></search><sort><creationdate>202105</creationdate><title>Chemometry‐assisted UV‐spectrophotmetric methods for the simultaneous determination of paritaprevir, ritonavir, and ombitasvir in their combined tablet dosage forms: A comparative study</title><author>Sayed, Rania Adel ; Ibrahim, Adel Ehab ; Sharaf, Yasmine Ahmed</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2939-c3c8f276cc823de1bf582e030f654c9ce2b71d26debd76975a40dfcd2fc83d893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antiretroviral drugs</topic><topic>Antiviral drugs</topic><topic>Chemometrics</topic><topic>Comparative studies</topic><topic>Correlation coefficient</topic><topic>Correlation coefficients</topic><topic>Dosage</topic><topic>Drug dosages</topic><topic>Drugs</topic><topic>Genetic algorithms</topic><topic>Hepatitis</topic><topic>Laboratories</topic><topic>Least squares</topic><topic>Medicine</topic><topic>Multivariate analysis</topic><topic>multivariate chemometry</topic><topic>ombitasvir</topic><topic>paritaprevir</topic><topic>Quality control</topic><topic>Ritonavir</topic><topic>Scientific papers</topic><topic>Spectrophotometry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sayed, Rania Adel</creatorcontrib><creatorcontrib>Ibrahim, Adel Ehab</creatorcontrib><creatorcontrib>Sharaf, Yasmine Ahmed</creatorcontrib><collection>CrossRef</collection><collection>Computer and Information Systems Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Technology Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><jtitle>Journal of chemometrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sayed, Rania Adel</au><au>Ibrahim, Adel Ehab</au><au>Sharaf, Yasmine Ahmed</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chemometry‐assisted UV‐spectrophotmetric methods for the simultaneous determination of paritaprevir, ritonavir, and ombitasvir in their combined tablet dosage forms: A comparative study</atitle><jtitle>Journal of chemometrics</jtitle><date>2021-05</date><risdate>2021</risdate><volume>35</volume><issue>5</issue><epage>n/a</epage><issn>0886-9383</issn><eissn>1099-128X</eissn><abstract>The ternary mixture under study is a recent hepatitis‐C antiviral medicine composed of three new directly acting antiviral drugs, namely, ombitasvir, paritaprevir, and ritonavir. They are co‐formulated as a single‐dose combined tablet dosage form. With more than 170 million infected patients worldwide, a large production scales of antivirals medicine is expected, and hence, new simple and fast methodologies are required to cover millions of analyses that are done routinely in the different pharmaceutical quality control and research laboratories. Ultraviolet spectrophotometry represents sensitive, fast, and cheap tool of analysis in all research and quality control laboratories that can cover the massive quality control of these regimens. However, the simultaneous determination of these three drugs using multivariate chemometric methods represents a high challenge as their spectra are strongly overlapping besides the large difference in their potency within the same tablet. In this research paper, four new different multivariate chemometric methods were developed for their simultaneous determination, namely, classical least square (CLS), principal component regression (PCR), partial least squares (PLS), and genetic algorithm‐partial least squares (GA‐PLS) techniques. The validated methods do not require extraction, separation, or derivatization steps. A comparative study was conducted among the four developed methods. All methods provided satisfactory results, whereas GA‐PLS showed better analytical performance as it had the lowest error with good higher correlation coefficient. The methods were applied in the simultaneous determination of the three drugs in pure form and in their combined tablet dosage form. The comparison confirmed agreement of the values obtained for all techniques.
Ombitasvir, paritaprevir, and ritonavir are coformulated as a single‐dose combined tablet dosage form. In this research paper, four new different multivariate chemometric methods were developed for their simultaneous determination, namely, classical least square (CLS), principal component regression (PCR), partial least squares (PLS), and genetic algorithm‐partial least squares (GA‐PLS) techniques. The methods were applied in the simultaneous determination of the three drugs in pure form and in their combined tablet dosage form.</abstract><cop>Chichester</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/cem.3339</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0001-7421-1220</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0886-9383 |
ispartof | Journal of chemometrics, 2021-05, Vol.35 (5), p.n/a |
issn | 0886-9383 1099-128X |
language | eng |
recordid | cdi_proquest_journals_2525442775 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Antiretroviral drugs Antiviral drugs Chemometrics Comparative studies Correlation coefficient Correlation coefficients Dosage Drug dosages Drugs Genetic algorithms Hepatitis Laboratories Least squares Medicine Multivariate analysis multivariate chemometry ombitasvir paritaprevir Quality control Ritonavir Scientific papers Spectrophotometry |
title | Chemometry‐assisted UV‐spectrophotmetric methods for the simultaneous determination of paritaprevir, ritonavir, and ombitasvir in their combined tablet dosage forms: A comparative study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T02%3A29%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chemometry%E2%80%90assisted%20UV%E2%80%90spectrophotmetric%20methods%20for%20the%20simultaneous%20determination%20of%20paritaprevir,%20ritonavir,%20and%20ombitasvir%20in%20their%20combined%20tablet%20dosage%20forms:%20A%20comparative%20study&rft.jtitle=Journal%20of%20chemometrics&rft.au=Sayed,%20Rania%20Adel&rft.date=2021-05&rft.volume=35&rft.issue=5&rft.epage=n/a&rft.issn=0886-9383&rft.eissn=1099-128X&rft_id=info:doi/10.1002/cem.3339&rft_dat=%3Cproquest_cross%3E2525442775%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2939-c3c8f276cc823de1bf582e030f654c9ce2b71d26debd76975a40dfcd2fc83d893%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2525442775&rft_id=info:pmid/&rfr_iscdi=true |